Copyright Reports & Markets. All rights reserved.

Global Vasomotor Symptoms of Menopause Treatment Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Vasomotor Symptoms of Menopause Treatment Market Overview

      • 1.1 Product Overview and Scope of Vasomotor Symptoms of Menopause Treatment
      • 1.2 Vasomotor Symptoms of Menopause Treatment Segment by Type
        • 1.2.1 Global Vasomotor Symptoms of Menopause Treatment Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Estetrol
        • 1.2.3 Fezolinetant
        • 1.2.4 FP-101
        • 1.2.5 HBN-2
        • 1.2.6 Others
      • 1.3 Vasomotor Symptoms of Menopause Treatment Segment by Application
        • 1.3.1 Vasomotor Symptoms of Menopause Treatment Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Homecare
        • 1.3.4 Clinic
      • 1.3 Global Vasomotor Symptoms of Menopause Treatment Market by Region
        • 1.3.1 Global Vasomotor Symptoms of Menopause Treatment Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Vasomotor Symptoms of Menopause Treatment Market Size
        • 1.4.1 Global Vasomotor Symptoms of Menopause Treatment Revenue (2014-2025)
        • 1.4.2 Global Vasomotor Symptoms of Menopause Treatment Production (2014-2025)

      2 Global Vasomotor Symptoms of Menopause Treatment Market Competition by Manufacturers

      • 2.1 Global Vasomotor Symptoms of Menopause Treatment Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Vasomotor Symptoms of Menopause Treatment Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Vasomotor Symptoms of Menopause Treatment Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Vasomotor Symptoms of Menopause Treatment Production Sites, Area Served, Product Types
      • 2.5 Vasomotor Symptoms of Menopause Treatment Market Competitive Situation and Trends
        • 2.5.1 Vasomotor Symptoms of Menopause Treatment Market Concentration Rate
        • 2.5.2 Vasomotor Symptoms of Menopause Treatment Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Vasomotor Symptoms of Menopause Treatment Production Market Share by Regions

      • 3.1 Global Vasomotor Symptoms of Menopause Treatment Production Market Share by Regions
      • 3.2 Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Vasomotor Symptoms of Menopause Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Vasomotor Symptoms of Menopause Treatment Production
        • 3.4.1 North America Vasomotor Symptoms of Menopause Treatment Production Growth Rate (2014-2019)
        • 3.4.2 North America Vasomotor Symptoms of Menopause Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Vasomotor Symptoms of Menopause Treatment Production
        • 3.5.1 Europe Vasomotor Symptoms of Menopause Treatment Production Growth Rate (2014-2019)
        • 3.5.2 Europe Vasomotor Symptoms of Menopause Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Vasomotor Symptoms of Menopause Treatment Production (2014-2019)
        • 3.6.1 China Vasomotor Symptoms of Menopause Treatment Production Growth Rate (2014-2019)
        • 3.6.2 China Vasomotor Symptoms of Menopause Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Vasomotor Symptoms of Menopause Treatment Production (2014-2019)
        • 3.7.1 Japan Vasomotor Symptoms of Menopause Treatment Production Growth Rate (2014-2019)
        • 3.7.2 Japan Vasomotor Symptoms of Menopause Treatment Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Vasomotor Symptoms of Menopause Treatment Consumption by Regions

      • 4.1 Global Vasomotor Symptoms of Menopause Treatment Consumption by Regions
      • 4.2 North America Vasomotor Symptoms of Menopause Treatment Consumption (2014-2019)
      • 4.3 Europe Vasomotor Symptoms of Menopause Treatment Consumption (2014-2019)
      • 4.4 China Vasomotor Symptoms of Menopause Treatment Consumption (2014-2019)
      • 4.5 Japan Vasomotor Symptoms of Menopause Treatment Consumption (2014-2019)

      5 Global Vasomotor Symptoms of Menopause Treatment Production, Revenue, Price Trend by Type

      • 5.1 Global Vasomotor Symptoms of Menopause Treatment Production Market Share by Type (2014-2019)
      • 5.2 Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type (2014-2019)
      • 5.3 Global Vasomotor Symptoms of Menopause Treatment Price by Type (2014-2019)
      • 5.4 Global Vasomotor Symptoms of Menopause Treatment Production Growth by Type (2014-2019)

      6 Global Vasomotor Symptoms of Menopause Treatment Market Analysis by Applications

      • 6.1 Global Vasomotor Symptoms of Menopause Treatment Consumption Market Share by Application (2014-2019)
      • 6.2 Global Vasomotor Symptoms of Menopause Treatment Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Vasomotor Symptoms of Menopause Treatment Business

      • 7.1 Amgen Inc.
        • 7.1.1 Amgen Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
        • 7.1.2 Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
        • 7.1.3 Amgen Inc. Vasomotor Symptoms of Menopause Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 EndoCeutics, Inc.
        • 7.2.1 EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
        • 7.2.2 Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
        • 7.2.3 EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Euroscreen S.A.
        • 7.3.1 Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
        • 7.3.2 Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
        • 7.3.3 Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 MenoGeniX, Inc.
        • 7.4.1 MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
        • 7.4.2 Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
        • 7.4.3 MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Mithra Pharmaceuticals S.A.
        • 7.5.1 Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
        • 7.5.2 Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
        • 7.5.3 Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Pherin Pharmaceuticals, Inc.
        • 7.6.1 Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
        • 7.6.2 Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
        • 7.6.3 Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Pivot Pharmaceuticals Inc
        • 7.7.1 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
        • 7.7.2 Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
        • 7.7.3 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Radius Health, Inc.
        • 7.8.1 Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
        • 7.8.2 Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
        • 7.8.3 Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 TherapeuticsMD, Inc.
        • 7.9.1 TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
        • 7.9.2 Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
        • 7.9.3 TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served

      8 Vasomotor Symptoms of Menopause Treatment Manufacturing Cost Analysis

      • 8.1 Vasomotor Symptoms of Menopause Treatment Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Vasomotor Symptoms of Menopause Treatment
      • 8.4 Vasomotor Symptoms of Menopause Treatment Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Vasomotor Symptoms of Menopause Treatment Distributors List
      • 9.3 Vasomotor Symptoms of Menopause Treatment Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Vasomotor Symptoms of Menopause Treatment Market Forecast

      • 11.1 Global Vasomotor Symptoms of Menopause Treatment Production, Revenue Forecast
        • 11.1.1 Global Vasomotor Symptoms of Menopause Treatment Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Vasomotor Symptoms of Menopause Treatment Price and Trend Forecast (2019-2025)
      • 11.2 Global Vasomotor Symptoms of Menopause Treatment Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Vasomotor Symptoms of Menopause Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Vasomotor Symptoms of Menopause Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Vasomotor Symptoms of Menopause Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Vasomotor Symptoms of Menopause Treatment Production, Revenue Forecast (2019-2025)
      • 11.3 Global Vasomotor Symptoms of Menopause Treatment Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Vasomotor Symptoms of Menopause Treatment Consumption Forecast (2019-2025)
        • 11.3.2 Europe Vasomotor Symptoms of Menopause Treatment Consumption Forecast (2019-2025)
        • 11.3.3 China Vasomotor Symptoms of Menopause Treatment Consumption Forecast (2019-2025)
        • 11.3.4 Japan Vasomotor Symptoms of Menopause Treatment Consumption Forecast (2019-2025)
      • 11.4 Global Vasomotor Symptoms of Menopause Treatment Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Vasomotor Symptoms of Menopause Treatment Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Vasomotor Symptoms of Menopause Treatment market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Vasomotor Symptoms of Menopause Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Vasomotor Symptoms of Menopause Treatment market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Amgen Inc.
        EndoCeutics, Inc.
        Euroscreen S.A.
        MenoGeniX, Inc.
        Mithra Pharmaceuticals S.A.
        Pherin Pharmaceuticals, Inc.
        Pivot Pharmaceuticals Inc
        Radius Health, Inc.
        TherapeuticsMD, Inc.

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Estetrol
        Fezolinetant
        FP-101
        HBN-2
        Others

        Segment by Application
        Hospital
        Homecare
        Clinic

        Buy now